By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Orexo AB 

Box 303

Uppsala    SE-751 05  Sweden
Phone: 46-0-18-780-88-00 Fax: 46-0-18-780-88-88


SEARCH JOBS


Industry
Pharmaceutical






Company News
Orexo AB (ORXOF): Interim Report January-June 2014 7/11/2014 9:39:01 AM
Orexo AB (ORXOF) Added To Russell Global Index 6/30/2014 11:22:47 AM
Orexo AB (ORXOF) Added To Russell Global Index 6/30/2014 8:10:12 AM
Orexo AB (ORXOF) Commences Patent Infringement Litigation Against Actavis (ACT) 6/27/2014 7:23:12 AM
Orexo AB (ORXOF) Release: Top-Line Data From A Phase 3 Clinical Trial Demonstrates That Zubsolv® Is As Effective As Suboxone® Film In The Treatment Of Opioid Dependence 6/25/2014 8:14:57 AM
Orexo AB (ORXOF) Release: Positive Top-Line Results From Two Phase 3 Clinical Trials That Assessed ZubsolvĀ® For Induction Of Buprenorphine Maintenance Therapy 6/23/2014 7:44:03 AM
Orexo AB (ORXOF) Publishes Bond Prospectus And Applies For Listing Of Its Bond Loan On NASDAQ OMX Stockholm 6/9/2014 1:57:17 PM
Number Of Shares And Votes In Orexo AB (ORXOF) 5/30/2014 9:38:35 AM
Orexo AB (ORXOF) Announces New Partner For The Commercialization Of Zubsolv® In The United States 5/20/2014 9:42:28 AM
Orexo AB (ORXOF) Issues A SEK 500 Million Bond Loan On The Swedish Bond Market 4/30/2014 6:36:51 AM
12345678910...
//-->